Constitutive opsin signaling: Night blindness or retinal degeneration?

Trends in Molecular Medicine

Volumn 10, Issue 4, 2004, Pages 150-157

  Lem, Janis ^a,b   Fain, Gordon L ^c  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11 CIS RETINAL; CALCIUM; CALCIUM CHANNEL; CYCLIC GMP; OPSIN; RETINA S ANTIGEN; RETINOL; RETINOL DEHYDROGENASE; RHODOPSIN KINASE; SCHIFF BASE; TRANSDUCIN;

APOPTOSIS; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL CULTURE; CELL DEATH; CENTRAL NERVOUS SYSTEM; CHROMATOPHORE; DEPHOSPHORYLATION; GENE MUTATION; HUMAN; ILLUMINATION; MEMBRANE DEPOLARIZATION; NERVE CELL; NIGHT BLINDNESS; NONHUMAN; PHOTORECEPTOR; PHOTOTRANSDUCTION; PIGMENT EPITHELIUM; RETINA DEGENERATION; RETINA ROD; REVIEW; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ANIMALIA; MUS MUSCULUS;

EID: 1642603437     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2004.02.009     Document Type: Article

References (56)

1. Woodruff M.L., et al. Spontaneous activity of opsin apoprotein is a cause of Leber congenital amaurosis. Nat. Genet. 35:2003;158-164.
2. Fain G.L., Lisman J.E. Photoreceptor degeneration in vitamin A deprivation and retinitis pigmentosa: the equivalent light hypothesis. Exp. Eye Res. 57:1993;335-340.
3. 2+, and photoreceptor death: new evidence for the equivalent-light hypothesis from arrestin knockout mice. Invest. Ophthalmol. Vis. Sci. 40:1999;2770-2772.
4. Dryja T.P. Molecular genetics of Oguchi disease, fundus albipunctatus, and other forms of stationary night blindness: LVII Edward Jackson memorial lecture. Am. J. Ophthalmol. 130:2000;547-563.
5. Fain G.L. Sensory Transduction. 2003;Sinauer, Sunderland, MA.
6. Xu J., et al. Prolonged photoresponses in transgenic mouse rods lacking arrestin. Nature. 389:1997;505-509.
7. Chen C.-K., et al. Abnormal photoresponses and light-induced apoptosis in rods lacking rhodopsin kinase. Proc. Natl. Acad. Sci. U. S. A. 96:1999;3718-3722.
8. Redmond T.M., et al. Rpe65 is necessary for production of 11-cis-vitamin A in the retinal visual cycle. Nat. Genet. 20:1998;344-351.
9. Ablonczy Z., et al. 11-cis-retinal reduces constitutive opsin phosphorylation and improves quantum catch in retinoid-deficient mouse rod photoreceptors. J. Biol. Chem. 277:2002;40491-40498.
10. -/- mice during development and aging. Invest. Ophthalmol. Vis. Sci. 44:2003;310-315.
11. Rao V.R., Oprian D.D. Activating mutations of rhodopsin and other G protein-coupled receptors. Annu. Rev. Biophys. Biomol. Struct. 25:1996;287-314.
12. Gross A.K., et al. Characterization of rhodopsin congenital night blindness mutant T94I. Biochemistry. 42:2003;2009-2015.
13. Gross A.K., et al. Slow binding of retinal to rhodopsin mutants G90D and T94D. Biochemistry. 42:2003;2002-2008.
14. Jin S., et al. Opsin activation as a cause of congenital night blindness. Nat. Neurosci. 6:2003;731-735.
15. Dryja T.P., et al. Heterozygous missense mutation in the rhodopsin gene as a cause of congenital stationary night blindness. Nat. Genet. 4:1993;280-283.
16. Rao V.R., et al. Rhodopsin mutation G90D and a molecular mechanism for congenital night blindness. Nature. 367:1994;639-641.
17. Sieving P.A., et al. Constitutive 'light' adaptation in rods from G90D rhodopsin: a mechanism for human congenital nightblindness without rod cell loss. J. Neurosci. 21:2001;5449-5460.
18. Sieving P.A., et al. Dark-light: model for nightblindness from the human rhodopsin Gly-90→Asp mutation. Proc. Natl. Acad. Sci. U. S. A. 92:1995;880-884.
19. Ramon E., et al. Unusual thermal and conformational properties of the rhodopsin congenital night blindness mutant Thr-94-Ile. J. Biol. Chem. 278:2003;6427-6432.
20. Cornwall M.C., Fain G.L. Bleached pigment activates transduction in isolated rods of the salamander retina. J. Physiol. 480:1994;261-279.
21. Melia T.J. Jr, et al. A comparison of the efficiency of G protein activation by ligand-free and light-activated forms of rhodopsin. Biophys. J. 73:1997;3182-3191.
22. Defoe D.M., Bok D. Rhodopsin chromophore exchanges among opsin molecules in the dark. Invest. Ophthalmol. Vis. Sci. 24:1983;1211-1226.
23. Robinson P.R., et al. Constitutively active mutants of rhodopsin. Neuron. 9:1992;719-725.
24. Li T., et al. Constitutive activation of phototransduction by K296E opsin is not a cause of photoreceptor degeneration. Proc. Natl. Acad. Sci. U. S. A. 92:1995;3551-3555.
25. Keen T.J., et al. Autosomal dominant retinitis pigmentosa: four new mutations in rhodopsin, one of them in the retinal attachment site. Genomics. 11:1991;199-205.
26. Dowling J.E., Wald G. Vitamin A deficiency and night blindness. Proc. Natl. Acad. Sci. U. S. A. 44:1958;648-661.
27. Dowling J.E., Wald G. The biological function of vitamin A acid. Proc. Natl. Acad. Sci. U. S. A. 46:1960;587-608.
28. Hao W., et al. Evidence for two apoptotic pathways in light-induced retinal degeneration. Nat. Genet. 32:2002;254-260.
29. Yamamoto S., et al. Defects in the rhodopsin kinase gene in the Oguchi form of stationary night blindness. Nat. Genet. 15:1997;175-178.
30. Cideciyan A.V., et al. Null mutation in the rhodopsin kinase gene slows recovery kinetics of rod and cone phototransduction in man. Proc. Natl. Acad. Sci. U. S. A. 95:1998;328-333.
31. Fuchs S., et al. A homozygous 1-base pair deletion in the arrestin gene is a frequent cause of Oguchi disease in Japanese. Nat. Genet. 10:1995;360-362.
32. Nakazawa M., et al. Arrestin gene mutations in autosomal recessive retinitis pigmentosa. Arch. Ophthalmol. 116:1998;498-501.
33. Van Hooser J.P., et al. Rapid restoration of visual pigment and function with oral retinoid in a mouse model of childhood blindness. Proc. Natl. Acad. Sci. U. S. A. 97:2000;8623-8628.
34. Dryja T.P., et al. Mutations in the gene encoding the α subunit of the rod cGMP-gated channel in autosomal recessive retinitis pigmentosa. Proc. Natl. Acad. Sci. U. S. A. 92:1995;10177-10181.
35. Lisman J., Fain G. Support for the equivalent light hypothesis for RP. Nat. Med. 1:1995;1254-1255.
36. Semple-Rowland S.L., et al. A null mutation in the photoreceptor guanylate cyclase gene causes the retinal degeneration chicken phenotype. Proc. Natl. Acad. Sci. U. S. A. 95:1998;1271-1276.
37. Batten, M.L. et al. (2003) Lecithin:retinol acyltransferase (LRAT) is essential for retention of retinyl esters in the eye and in the liver. J. Biol. Chem. 10.1074/jbc.M132410200 (www.jbc.org).
38. Thompson D.A., et al. Mutations in the gene encoding lecithin retinol acyltransferase are associated with early-onset severe retinal dystrophy. Nat. Genet. 28:2001;123-124.
39. Yau K.W., Nakatani K. Cation selectivity of light-sensitive conductance in retinal rods. Nature. 309:1984;352-354.
40. Hodgkin A.L., et al. The ionic selectivity and calcium dependence of the light-sensitive pathway in toad rods. J. Physiol. 358:1985;447-468.
41. Matthews H.R., Fain G.L. The effect of light on outer segment calcium in salamander rods. J. Physiol. 552:2003;763-776.
42. Kluck R.M., et al. Calcium chelators induce apoptosis-evidence that raised intracellular ionized calcium is not essential for apoptosis. Biochim. Biophys. Acta. 1223:1994;247-254.
43. Scott B.S., Fisher K.C. Potassium concentration and number of neurons in cultures of dissociated ganglia. Exp. Neurol. 27:1970;16-22.
44. Gallo V., et al. The role of depolarization in the survival and differentiation of cerebellar granule cells in culture. J. Neurosci. 7:1987;2203-2213.
45. 2+ determine nerve growth factor dependence of sympathetic ganglion cells. Proc. Natl. Acad. Sci. U. S. A. 86:1989;6421-6425.
46. Franklin J.L., Johnson E.M. Jr. Elevated intracellular calcium blocks programmed neuronal death. Ann. N. Y. Acad. Sci. 747:1994;195-204.
47. 2+ influx but not Trk activation. J. Neurosci. 15:1995;643-664.
48. Soler R.M., et al. Calmodulin is involved in membrane depolarization-mediated survival of motoneurons by phosphatidylinositol-3 kinase and MAPK independent pathways. J. Neurosci. 18:1998;1230-1239.
49. Agapite J., Steller H. Neuronal cell death. Cowan W.M., et al. In Molecular and Cellular Approaches to Neural Development. 1997;264-289 Oxford University Press.
50. Yuan J., et al. Diversity in the mechanisms of neuronal cell death. Neuron. 40:2003;401-413.
51. Lipton S.A., Kater S.B. Neurotransmitter regulation of neuronal outgrowth, plasticity and survival. Trends Neurosci. 12:1989;265-270.
52. Woodruff M.L., et al. Measurement of cytoplasmic calcium concentration in the rods of wild-type and transducin knock-out mice. J. Physiol. 542:2002;843-854.
53. Katsanis N., et al. Fundus albipunctatus and retinitis punctata albescens in a pedigree with an R150Q mutation in RLBP1. Clin. Genet. 59:2001;424-429.
54. Saari J.C., et al. Visual cycle impairment in cellular retinaldehyde binding protein (CRALBP) knockout mice results in delayed dark adaptation. Neuron. 29:2001;739-748.
55. Yamamoto H., et al. Mutations in the gene encoding 11-cis retinol dehydrogenase cause delayed dark adaptation and fundus albipunctatus. Nat. Genet. 22:1999;188-191.
56. Palczewski K., et al. Elevated level of protein phosphatase 2A activity in retinas of rd mice. Exp. Eye Res. 53:1991;101-105.